Articles dans des revues avec comité de lecture (24)
  1. 1. Quarto, G., Li Greci, A., Bizet, M., Penning, A., Primac, I., Murisier, F., Garcia-Martinez, L., Borges, R. L., Gao, Q., Cingaram, P., Calonne, E., Hassabi, B., Hubert, C., Herpoel, A., Putmans, P., Mies, F., Martin, J., Van Der Linden, L., Dube, G., Kumar, P., Soin, R., Kumar, A., Misra, A., Lan, J., Paque, M., Gupta, Y. K., Blomme, A., Close, P., Esteve, P. O., Caine, E., Riching, K. M., Gueydan, C., Daniels, D. L., Pradhan, S., Shiekhattar, R., David, Y., Morey, L., Jeschke, J., Deplus, R., Collignon, E., & Fuks, F. (2025). Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation. Cell, 188(4), 998-1018. doi:10.1016/j.cell.2024.12.009
  2. 2. Campbell, C., Funk, M. C., Hattori, Y., Hu, W., Jeschke, J., Lau, C. M., Ling, G. S., Liu, S., Lloréns-Rico, V., & Nemes, E. (2024). Women in STEM becoming independent: The journey to independence is an immensely gratifying odyssey. The Journal of experimental medicine, 221(7). doi:10.1084/jem.20240842
  3. 3. Chung, F. F.-L., Maldonado, S. G., Nemc, A., Bouaoun, L., Cahais, V., Cuenin, C., Salle, A., Johnson, T., Ergüner, B., Laplana, M., Datlinger, P., Jeschke, J., Weiderpass, E., Kristensen, V., Delaloge, S., Fuks, F., Risch, A., Ghantous, A., Plass, C., Bock, C., Kaaks, R., & Herceg, Z. (2023). Buffy coat signatures of breast cancer risk in a prospective cohort study. Clinical Epigenetics, 15(1), 102. doi:10.1186/s13148-023-01509-6
  4. 4. Jeschke, J. (2023). Editorial: Advances in cancer detection and diagnosis: from liquid biopsies and molecular biomarkers to opportunistic intratumoral bacteria. Current opinion in oncology, 35(2), 114. doi:10.1097/CCO.0000000000000930
  5. 5. Penning, A., Jeschke, J., & Fuks, F. (2022). Why novel mRNA modifications are so challenging and what we can do about it. Nature reviews. Molecular cell biology, 23(6), 385-386. doi:10.1038/s41580-022-00485-8
  6. 6. Jeschke, J., Collignon, E., Al Wardi, C., Krayem, M., Bizet, M., Jia, Y., Garaud, S., Wimana, Z., Calonne, E., Hassabi, B., Morandini, R., Deplus, R., Putmans, P., Dube, G., Singh, N. K., Koch, A., Shostak, K., Rizzotto, L., Ross, R. L., Desmedt, C., Bareche, Y., Rothé, F., Lehmann-Che, J., Duterque-Coquillaud, M., Leroy, X., Menschaert, G., Teixeira, L., Guo, M., Limbach, P. A., Close, P., Chariot, A., Leucci, E., Ghanem, G., Yuan, B., Willard-Gallo, K., Sotiriou, C., Marine, J.-C., & Fuks, F. (2021). Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors. Nature Cancer, 2(6), 611-628. doi:10.1038/s43018-021-00223-7
  7. 7. Koch, A., Jeschke, J., Van Criekinge, W., van Engeland, M., & De Meyer, T. (2019). MEXPRESS update 2019. Nucleic acids research, 47(W1), W561-W565. doi:10.1093/nar/gkz445
  8. 8. Jeschke, J., Bizet, M., Desmedt, C., Calonne, E., Dedeurwaerder, S., Garaud, S., Koch, A., Larsimont, D., Salgado, R., Van den Eynden, G., Willard-Gallo, K., Bontempi, G., Defrance, M., Sotiriou, C., & Fuks, F. (2017). DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. The Journal of clinical investigation, 127(8), 3090-3102. doi:10.1172/JCI91095
  9. 9. Van Vlodrop, I. J. H., Joosten, S. C., De Meyer, T., Smits, K. M., Van Neste, L., Melotte, V., Baldewijns, M. M. L. L. M., Schouten, L. J., van den Brandt, P. A., Jeschke, J., Yi, J. M., Schuebel, K. K., Ahuja, N., Herman, J. G., Aarts, M. J., Bosman, F. T., Van Criekinge, W., & van Engeland, M. (2017). A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients. Clinical cancer research, 23(8), 2006-2018. doi:10.1158/1078-0432.CCR-16-1236
  10. 10. Siebenkäs, C., Chiappinelli, K. K., Guzzetta, A. A., Sharma, A., Jeschke, J., Vatapalli, R., Baylin, S. B., & Ahuja, N. (2017). Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells. PloS one, 12(6), e0179501. doi:10.1371/journal.pone.0179501
  11. 11. Jeschke, J., Collignon, E., & Fuks, F. (2016). Portraits of TET-mediated DNA hydroxymethylation in cancer. Current opinion in genetics & development, 36, 16-26. doi:10.1016/j.gde.2016.01.004
  12. 12. Koch, A., De Meyer, T., Jeschke, J., & Van Criekinge, W. (2015). MEXPRESS: Visualizing expression, DNA methylation and clinical TCGA data. BMC genomics, 16(1), 636. doi:10.1186/s12864-015-1847-z
    13. << Précédent 1 2 3 Suivant >>